menu search

Moderna stock crash steepens—but expert declares incoming flu vaccine results could show ‘superiority'

Moderna stock fell 4% despite the bullish projection, pushing shares down nearly 72% below their August all-time high....

February 23, 2022, 10:34 am

Moderna stock crash steepens—but expert declares incoming flu vaccine results could show ‘superiority'

Moderna stock fell 4% despite the bullish projection, pushing shares down nearly 72% below their August all-time high....

February 23, 2022, 10:34 am

Moderna and thermo fisher enter long-term agreement on large-scale manufacturing of covid vaccine

Moderna Inc. MRNA, -0.53% and life-sciences company Thermo Fisher Scientific Inc. TMO, -1.35% said Wednesday they have entered a long-term agreement t...

February 23, 2022, 8:36 am

Moderna and thermo fisher enter long-term agreement on large-scale manufacturing of covid vaccine

Moderna Inc. MRNA, -0.53% and life-sciences company Thermo Fisher Scientific Inc. TMO, -1.35% said Wednesday they have entered a long-term agreement t...

February 23, 2022, 8:36 am

Moderna and thermo fisher enter long-term agreement on large-scale manufacturing of covid vaccine

Moderna Inc. MRNA, -0.53% and life-sciences company Thermo Fisher Scientific Inc. TMO, -1.35% said Wednesday they have entered a long-term agreement t...

February 23, 2022, 8:36 am

Glaxosmithkline and sanofi plan to submit data from covid-19 booster and phase iii trials for approval

GlaxoSmithKline PLC (LSE:GSK) and Sanofi SA said they plan to submit data from their booster and Phase III trials as a basis for their regulatory appl...

February 23, 2022, 6:19 am

Glaxosmithkline and sanofi plan to submit data from covid-19 booster and phase iii trials for approval

GlaxoSmithKline PLC (LSE:GSK) and Sanofi SA said they plan to submit data from their booster and Phase III trials as a basis for their regulatory appl...

February 23, 2022, 6:19 am

Glaxosmithkline and sanofi plan to submit data from covid-19 booster and phase iii trials for approval

GlaxoSmithKline PLC (LSE:GSK) and Sanofi SA said they plan to submit data from their booster and Phase III trials as a basis for their regulatory appl...

February 23, 2022, 6:19 am

Dow jones newswires: sanofi, gsk to seek approval for covid-19 vaccine after positive trial results

Sanofi SA SNY, -0.80% and GlaxoSmithKline PLC GSK, -0.81% said Wednesday that their jointly-developed coronavirus v...

February 23, 2022, 6:19 am

Dow jones newswires: sanofi, gsk to seek approval for covid-19 vaccine after positive trial results

Sanofi SA SNY, -0.80% and GlaxoSmithKline PLC GSK, -0.81% said Wednesday that their jointly-developed coronavirus v...

February 23, 2022, 6:19 am

Dow jones newswires: sanofi, gsk to seek approval for covid-19 vaccine after positive trial results

Sanofi SA SNY, -0.80% and GlaxoSmithKline PLC GSK, -0.81% said Wednesday that their jointly-developed coronavirus v...

February 23, 2022, 6:19 am

Why ocugen stock is skyrocketing today

The FDA lifted a clinical hold that had been preventing Ocugen from starting a U.S.-based phase 3 clinical study of its COVID-19 v...

February 22, 2022, 12:15 pm

Why ocugen stock is skyrocketing today

The FDA lifted a clinical hold that had been preventing Ocugen from starting a U.S.-based phase 3 clinical study of its COVID-19 v...

February 22, 2022, 12:15 pm

Why ocugen stock is skyrocketing today

The FDA lifted a clinical hold that had been preventing Ocugen from starting a U.S.-based phase 3 clinical study of its COVID-19 v...

February 22, 2022, 12:15 pm

Moderna offers deep value as drug pipeline flows fast

MRNA stock has fallen into the buy zone, providing a prime opportunity as Moderna develops and commercializes multiple v...

February 22, 2022, 11:37 am

Moderna offers deep value as drug pipeline flows fast

MRNA stock has fallen into the buy zone, providing a prime opportunity as Moderna develops and commercializes multiple v...

February 22, 2022, 11:37 am

Moderna offers deep value as drug pipeline flows fast

MRNA stock has fallen into the buy zone, providing a prime opportunity as Moderna develops and commercializes multiple v...

February 22, 2022, 11:37 am

Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate

Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...

February 22, 2022, 10:30 am

Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate

Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...

February 22, 2022, 10:30 am

Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate

Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...

February 22, 2022, 10:30 am


Search within

Pages Search Results: